United States and France : Cegedim Relationship Management and EKR Therapeutics Inc. announced that EKR has contracted for Mobile Intelligence  on the iPad, and will be the first customer to implement this innovative Customer Relationship Management (CRM) solution, the first of its kind in the Life Sciences industry. Cegedim Relationship Management is the world’s leading provider of pharmaceutical CRM with a 35% global market share; and EKR Therapeutics is a specialty pharmaceutical company focused on identifying, fostering and targeting the growth of products to serve the needs of the acute-care hospital setting.

Sales forces and account teams of Life Sciences companies require comprehensive tools to manage customer relationships. Mobile Intelligence promotes visibility, collaboration and analysis, which increases efficiency and enriches stakeholder interactions. iPad deployment further enhances the value of Mobile Intelligence because it offers the benefits of mobility and new location-based services, as well as other Mobile Intelligence features such as multimedia detailing and electronic signature capture.

“The success of our business depends on customer relationships,” said John E. Bailye, Chief Executive Officer of EKR Therapeutics. “Being the first in our industry to use state-of-the-art technology like the iPad is characteristic of our commitment to sales force innovation. We are confident it will improve communication with healthcare providers and result in more productive interactions.”

The complete Cegedim solution, which will be leveraged by EKR Therapeutics’ institution-based key account managers, includes:

* Mobile Intelligence Multi-Tenant SaaS on the iPad

* Help Desk and Data & Technical Services

* Xtelligence Dashboard (advanced analytics)

“This solution is proof of Cegedim’s culture of advancement,” explained Angela Miccoli, President, Americas of Cegedim Relationship Management. “Our team of innovators, empowered by the industry knowledge gained in the 40+ years Cegedim has been serving the Life Sciences, immediately realized the iPad could benefit our customers. Now, we are proud to be working with EKR Therapeutics, and to be the first company in our space to bring this technology to our customers so that they can better compete in an ever-evolving marketplace.”

To learn more about Mobile Intelligence for the iPad, please visit the Cegedim Relationship Management website.